Menarini

13.05.2020 • News

Menarini to Buy Stemline Therapeutics for $677 Million

Italian pharmaceuticals and diagnostics company Menarini is to buy US biopharma Stemline Therapeutics in a deal valued at up to $677 million.

11.05.2020 • News

Menarini to Buy Stemline Therapeutics for $677 Million

09.02.2015 • News

Moberg Pharma Extends Distribution Agreement with Menarini

Top-Feature

IMCD Deutschland GmbH

"transport logistic": Ecocool with packaging solutions for pharmaceutical transports — focus on sustainability and cargo monitoring

Interview

Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Menarini

Menarini to Buy Stemline Therapeutics for $677 Million

Menarini to Buy Stemline Therapeutics for $677 Million

Moberg Pharma Extends Distribution Agreement with Menarini

Top-Feature

Fostering Innovation and Collaboration

Maximize the Potential of Spent Hydroprocessing Catalysts

Future Prospects in Green Chemistry

"transport logistic": Ecocool with packaging solutions for pharmaceutical transports — focus on sustainability and cargo monitoring

Interview

Fostering Innovation and Collaboration

Newsletter & e-edition